Abionic is focused on delivering true patient-centric point-of-care (near-patient) testing solutions available instantly at any time, from anywhere, whenever a patient needs it.
Abionic has developed an unparalleled nanofluidic technology-based diagnostic platform, combining nanoengineering, biochemical and medical sciences, to offer patients the fastest test results.
By bringing together the ultra-rapid diagnostic platform and the Pancreatic Stone Protein (PSP) biomarker, Abionic’s unique PSP Sepsis Test enables healthcare professionals to detect sepsis in just 5 minutes and up to 24h before the Standard of Care, with the potential to save millions of lives
Contact Information:
Address:
Abionic SA, Biopôle SE-B
Route de la Corniche 5, 1066 Epalinges
Switzerland
Tel: +41 21 353 33 80
Email: johanna.gardin@abionic.com
